The global heart pump market is predicted to grow at a CAGR of 21% CAGR during the forecast period, attaining a market size of USD 9.91 billion by 2030. The market is driven by the factors such as mounting occurrence of cardiovascular diseases, regulatory consent of numerous novel and innovative devices and vast disparity between the requirement and deliver of donor hearts are the primary growth drivers for heart pump device market. The heart pump device, a battery operated mechanical heart pump device, is implanted surgically to support the function of heart ventricles. It aids to preserve the pumping capability of a heart which cannot work effectively on its own.
According to Centers of Disease Control and Prevention (CDC), approximately 370,000 people die annually due to coronary heart disease in the U.S. It is the most common type of heart disease in the U.S. In addition, accordingWorld Health Organization (WHO) globally approximately 17.7 million people died from cardiovascular diseases in 2015. Mounting healthcare expenditure, refining healthcare infrastructure in developing countries and expanding geriatric population are also facilitating the growth for the heart pump device market. For instance, according to the WHO, globally in 2010 approximately 524 million people were aged 65 years and older and is expected to reach 1.5 billion in 2050.
Browse market insight and in-depth TOC on "Global Heart Pump Device Market – Analysis and Forecast (2023-2030)"
On the basis of product, the heart pump market is subdivided into intra-aortic balloon pumps, ventricular assist devices and the total artificial heart. Of all products, ventricular assist device market account the largest share and is also expected to grow at the fastest rate during the forecast period in the heart pump market, globally, due to technological improvements to advance the safety of these devices, mounting occurrence of heart failure and enhanced dependence on ventricular assistance devices for the management of heart failure. The ventricular assist devices are further divided into left ventricular assist devices, percutaneous ventricular assist devices, bi-ventricular assist devices, and right ventricular assist devices.
On the basis of type, the market is subdivided into implantable and extracorporeal. Implantable heart pumps accounted largest share and are expected to grow at fastest rate in the heart pump device market due to the technological improvements in implantable pump devices have composed them more dependable and safe.
Based on therapy, the market is segmented into bridge-to-candidacy (BTC), destination therapy (DT), bridge-to-transplant (BTT), and others. Destination therapy is expected to grow at the fastest rate during the forecast period in the market due to the increasing acceptance of DT as the technological advancements in heart pump technology improves the quality of life for patients. Moreover, bridge-to-candidacy accounted the largest share in the market due to effectual management decisions and patient results related with bridge-to-candidacy.
North America accounted for the major share in the heart pump device industry in 2017, globally as in the region the occurrence of cardiovascular diseases is increasing. For instance, according to the CDC, in the U.S. approximately 610,000 people die every year due to heart disease. Mounting number of regulatory approvals, expanding geriatric population, and promising reimbursement situation is also up surging growth of the North American heart pump device market.
Moreover, Asia-Pacific is observed to witness the fastest growth in the heart pump device market, owing to escalating awareness regarding heart pump device and favorable reimbursement policies. Mounting healthcare expenditure, large population base, improving healthcare expenditure, and mounting occurrence of skin diseases are some of the factors fuelling the growth of the Asia-Pacific heart pump device market. Asia-Pacific is observed to witness the fastest growth in the market, as in the region mounting occurrence of cardiovascular diseases is mounting. In addition, boosting healthcare expenditure, mounting medical tourism, expanding the geriatric population, and refining healthcare infrastructure is also creating a positive impact on the heart pump device industry growth in the region.
Abbott Laboratories, Reliantheart, Terumo, Abiomed, Medtronic Plc, Teleflex, CardiacAssist, Getinge, Jarvik Heart, Syncardia Systems, and Berlin Heart are the key players offering heart pump devices. Globally, the manufacturing companies trying to enter the heart pump device market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. In July 2018, Medtronic Plc received FDA approval for less invasive heart pump implant procedure. It is an HVAD System, for a left ventricular assist device (LVAD) which helps patients with advanced heart failure.
Global Heart Pump Device Market Coverage
Product Insight and Forecast 2018-2030
Type Insight and Forecast 2018-2030
Therapy Insight and Forecast 2018-2030
Heart Pump Device Market by Region
Rest of the World